SAI Parenterals unit Noumed Pharma extends AUD 30 million OTC deal in Australia 5 hrs ago
Noumed Pharmaceuticals, a subsidiary of SAI Parenterals, has extended an OTC supply deal with an Australian pharmacy chain. The deal is valued at AUD 30 million. The agreement covers over-the-counter pharmaceutical product supply in Australia.